Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes
Saved in:
Main Authors: | Zachary Freyberg, Ronald A. Codario |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1532414/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disease-Associated Dopamine Receptor D2 Variants Exhibit Functional Consequences Depending on Different Heterotrimeric G-Protein Subunit Combinations
by: Nele Niebrügge, et al.
Published: (2024-12-01) -
Synaptic enrichment and dynamic regulation of the two opposing dopamine receptors within the same neurons
by: Shun Hiramatsu, et al.
Published: (2025-01-01) -
Associations between inflammation and striatal dopamine D2-receptor availability in aging
by: Vanessa Crine, et al.
Published: (2025-01-01) -
T-2 toxin triggers depression-like behaviors via upregulation of dopamine transporter in nucleus accumbens of male mice
by: Zhigang Chen, et al.
Published: (2025-01-01) -
Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease
by: Aaron King, et al.
Published: (2025-03-01)